Kaori Masai is a visiting scholar of department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. I achieved my Ph.D. in medical science at the graduate school as stated above in 2023, and M.D. at Okayama University Medical School in 2018. I have been working at current position since 2023. My current interest is neurotoxic effects of maternal bisphenol A derivatives exposure, and amyloid beta clearance via glymphatic system. Moreover, I am contributing to investigate the mechanism of central and enteric nervous system damage in rotenone-induced Parkinson's disease mouse model. Previously, I found impairment of adult neurogenesis associated with region-specific glial activation in sporadic Alzheimer's disease mouse model. I also revealed neuroprotective effects of anti‑HMGB1 antibody against methamphetamine‑induced dopaminergic neurotoxicity. I belong to the Japan Neuroscience Society, and the Japanese Society for Neurochemistry.
Kaori Masai is a visiting scholar of department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. I achieved my Ph.D. in medical science at the graduate school as stated above in 2023, and M.D. at Okayama University Medical School in 2018. I have been working at current position since 2023. My current interest is neurotoxic effects of maternal bisphenol A derivatives exposure, and amyloid beta clearance via glymphatic system. Moreover, I am contributing to investigate the mechanism of central and enteric nervous system damage in rotenone-induced Parkinson's disease mouse model. Previously, I found impairment of adult neurogenesis associated with region-specific glial activation in sporadic Alzheimer's disease mouse model. I also revealed neuroprotective effects of anti‑HMGB1 antibody against methamphetamine‑induced dopaminergic neurotoxicity. I belong to the Japan Neuroscience Society, and the Japanese Society for Neurochemistry.